ArticleFrontiers in pediatrics2025
Epidemiology of inflammatory bowel disease-associated anemia in children and adolescents from 1990 to 2021: a global, regional analysis from the Global Burden of Disease Study.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Inflammatory bowel disease (IBD)-associated anemia cannot be ignored, as it can affect the growth and development of children and adolescents. This study aimed to report the global, regional, and national disease burden of IBD-associated anemia in children and adolescents. Methods: Data on the prevalence of IBD-associated anemia and years lived with disability were obtained from the Global Burden of Disease Study 2021. Joinpoint regression analysis, age-period -ohort modeling analysis, and decomposition analysis were performed. Finally, an ARIMA model was established to predict the disease burden up to 2041. Results: Anemia associated with IBD was most prevalent among adolescents aged 15-19 years, with significantly higher prevalence in females [11,487.26, 95% uncertainty interval (UI) = 8,826.54, 14,622.31] than in males (6,677.01, 95% UI = 5,179.56, 8,498.89). The age-standardized prevalence rate (ASPR) was highest in moderate anemia (17.5561, 95% UI = 14.9597, 20.8729). Joinpoint regression analysis suggested the ASPR of IBD-associated anemia in both males and females increased from 2005 to 2010 and then decreased after 2010. In the decomposition analysis, aging and population growth were the main drivers of changes in the prevalence of IBD-associated anemia. ASPR exhibits a fluctuating trend in males from 1990 to 2041 and is projected to remain stable in females from 2027 to 2041. Conclusion: The ASPR of IBD-associated anemia in children and adolescents increased from 2005 to 2010 and then decreased after reaching a peak in 2010. In the future, IBD-associated anemia will continue to pose a significant public health problem.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.